| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |